Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
3.52 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192.18 | 32.811 | 60.391 | 65.985 | 48.633 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.104 | 0.104 | 0.104 | 0.104 | 0.104 | 0.104 | 0.104 | 15.148 | 0.043 | 0.023 | 0.007 | 43.019 | 39.803 | 26.571 | 13.846 | 13.601 | 7.755 | 2.821 | 10.17 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.104 | -0.104 | -0.104 | -0.104 | -0.104 | -0.104 | -0.104 | -15.148 | -0.043 | -0.023 | 192.173 | -10.208 | 20.588 | 39.414 | 34.787 | -13.601 | -7.755 | -2.821 | -10.17 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -0.311 | 0.341 | 0.597 | 0.715 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 26.159 | 34.696 | 57.575 | 35.045 | 28.181 | 22.063 | 28.954 | 27.54 | 4.905 | 19.858 | 29.633 | 57.811 | 43.019 | 39.803 | 26.571 | 13.846 | 13.601 | 7.755 | 2.821 | 3.489 | 2.411 | 2.826 | 1.444 |
| General & Administrative Expenses
| 11.043 | 12.22 | 12.231 | 11.528 | 12.604 | 13.172 | 12.615 | 12.359 | 11.376 | 12.437 | 12.542 | 13.188 | 11.939 | 11.901 | 8.759 | 14.14 | 4.028 | 2.248 | 1.224 | 1.26 | 1.358 | 0.892 | 0.928 |
| Selling & Marketing Expenses
| 0 | -0.104 | -0.104 | -0.104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 11.043 | 12.116 | 12.127 | 11.424 | 12.604 | 13.172 | 12.615 | 12.359 | 11.376 | 12.437 | 12.542 | 13.188 | 11.939 | 11.901 | 8.759 | 14.14 | 4.028 | 2.248 | 1.224 | 1.26 | 1.358 | 0.892 | 0.928 |
| Other Expenses
| 0 | -23.209 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 37.202 | 46.812 | 69.702 | 46.469 | 40.785 | 35.235 | 41.569 | 39.899 | 16.281 | 32.295 | 42.175 | 70.999 | 54.958 | 51.704 | 35.33 | 27.986 | 17.629 | 10.003 | 4.045 | 4.749 | 3.769 | 3.718 | 2.372 |
| Operating Income
| -37.202 | -46.916 | -69.806 | -46.573 | -40.785 | -35.235 | -41.569 | -39.899 | -16.281 | -32.295 | -42.175 | 121.181 | -22.147 | 8.687 | 30.655 | 20.647 | -17.629 | -10.003 | -4.045 | -4.749 | -3.769 | -3.718 | -2.372 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.631 | -0.675 | 0.144 | 0.465 | 0.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.277 | 6.637 | 6.868 | 7.758 | 7.864 | 7.303 | 6.299 | 5.591 | 4.382 | 1.08 | 0.098 | 0.051 | 0.053 | 0.052 | 0.058 | 0.009 | 0.007 | 0.01 | 0.057 | 0.094 | 0.137 | 0.164 | 0.179 |
| Income Before Tax
| -30.925 | -40.279 | -62.938 | -38.815 | -32.921 | -27.932 | -35.27 | -34.308 | -11.899 | -31.215 | -42.077 | 121.232 | -22.094 | 8.739 | 30.713 | 20.656 | -17.622 | -9.993 | -3.988 | -4.655 | -3.632 | -3.554 | -2.193 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.631 | -0.673 | 0.145 | 0.465 | 0.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.226 | 0.243 | 0.231 | 0.349 | 0.221 | 0.251 | 0.197 | 0.123 | -3.833 | 0.12 | -0.098 | 4.1 | 6.1 | 7.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -31.151 | -40.522 | -63.169 | -39.164 | -33.142 | -28.183 | -35.467 | -34.431 | -8.066 | -31.335 | -41.979 | 117.132 | -28.194 | 1.539 | 30.713 | 20.656 | -17.622 | -9.993 | -3.988 | -4.655 | -3.632 | -3.554 | -2.193 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.609 | -0.859 | 0.025 | 0.465 | 0.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.37 | -0.48 | -0.75 | -0.47 | -0.4 | -0.34 | -0.43 | -0.41 | -0.097 | -0.38 | -0.5 | 1.41 | -0.34 | 0.02 | 0.37 | 0.25 | -0.22 | -0.21 | -0.084 | -0.098 | -0.077 | -0.35 | -0.22 |
| EPS Diluted
| -0.37 | -0.48 | -0.75 | -0.47 | -0.4 | -0.34 | -0.43 | -0.41 | -0.097 | -0.38 | -0.5 | 1.34 | -0.34 | 0.02 | 0.34 | 0.23 | -0.22 | -0.21 | -0.084 | -0.098 | -0.077 | -0.35 | -0.22 |
| EBITDA
| -37.202 | -46.916 | -69.702 | -38.711 | -40.785 | -35.235 | -41.465 | -34.204 | -16.281 | -32.295 | -42.168 | 121.188 | -22.14 | 8.695 | 30.662 | 20.653 | -17.624 | -9.999 | -4.041 | -4.745 | -3.765 | -3.714 | -2.367 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.631 | -0.675 | 0.144 | 0.465 | 0.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |